Skip to Content

Tag: clearance


Also Noted

Senseonics, Ascensia launch one-year CGM system 

September 17, 2024HME News Staff

GERMANTOWN, Md., and PARSIPPANY, N.J. – Senseonics and Ascensia Diabetes Care have announced that the U.S. Food and Drug Administration has cleared the next-generation Eversense 365 CGM, the first one-year CGM system. “The approval of Eversense 365 represents a significant leap in CGM innovation,” said Tim Goodnow, PhD, president and CEO of Senseonics. “Extending sensor longevity to a full year, coupled with seamless device connectivity and a high level of accuracy, provides...

Ascensia Diabetes Care, clearance, Continuous Glucose Monitor (CGM), Diabetes, Food & Drug Administration (FDA), Senseonics


Read Full Articlered right arrow icon